Jae Hyun Nam, Hee Jin Kwack, Woo Seob Ha, Jee-Eun Chung
언어
영어(ENG)
URL
https://www.earticle.net/Article/A418387
※ 기관로그인 시 무료 이용이 가능합니다.
4,000원
원문정보
초록
영어
Background: Intravenous fluid therapy is one of the most common interventions in critically ill patients. Normal saline is frequently used, but there have been some concerns about hyperchloremia. Due to closer to plasma composition, crystalloids have been used as alternatives to normal saline. However, the optimal choice of resuscitative fluids remains controversial. Methods: MEDLINE, EMBASE, and CENTRAL were comprehensively searched until July 2021 to compare balanced crystalloids with normal saline in critically ill patients with the risk factors for multiple organ dysfunction syndromes (MODS).The primary endpoint was composite mortality. Secondary outcomes were acute kidney injury (AKI)/acute renal failure (ARF), and new receipt of renal replacement therapy (RRT). Results: A total of 1,240 studies were searched, and finally, 8 randomized controlled trials and 5 cohort studies were included. In the meta-analysis of composite mortality of 30,710 patients, balanced crystalloids compared to normal saline were significantly associated with reduced mortality (OR 0.80, 95% CI 0.68-0.95). In AKI/ARF, balanced crystalloids had a lower risk than normal saline (OR 0.91, 95% CI 0.84-0.99). There was no difference between balanced crystalloids and normal saline in risk of new receipt of RRT (OR 0.91, 95% CI 0.80-1.04). Conclusion: In fluid resuscitation for patients at high risk of MODS, the use of balanced crystalloids showed a significantly lower incidence of mortality compared to normal saline.
목차
ABSTRACT Methods Search strategies Data extraction Quality Assessment Data synthesis and analysis Results Discussion Conclusion Acknowledgments Conflicts of Interest References
Jae Hyun Nam [ College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Department of Pharmaceutical Services, Hanyang University Hospital, Seoul 04763, Republic of Korea ]
Hee Jin Kwack [ 1College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do 15588, Republic of Korea ]
Woo Seob Ha [ 1College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do 15588, Republic of Korea ]
Jee-Eun Chung [ 1College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do 15588, Republic of Korea ]
Corresponding Author